Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS)
CNY 19.25
(-3.12%)
CNY 19.25
(-3.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 28.25 Million | 238.71 Million | 102.48 Million | 3.29 Million | 144.51 Million | 31.79 Million |
| Net Income | 112.62 Million | 84.74 Million | 69.55 Million | 121.5 Million | 120.32 Million | 100.53 Million |
| Depreciation & Amortization | 58.88 Million | 51.02 Million | 48.16 Million | 43.51 Million | 41.5 Million | 35.5 Million |
| Deferred income taxes | -1.49 Million | 3.02 Million | 6.95 Million | -13.6 Million | -559.75 Thousand | -293 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -192.96 Million | 78.8 Million | -35.61 Million | -182.82 Million | -34.75 Million | -114.55 Million |
| Other non-cash items | 19.07 Million | 24.13 Million | 20.37 Million | 21.1 Million | 17.42 Million | 10.3 Million |
| Investing Cash Flow | -524.21 Million | -411.59 Million | -117.09 Million | -77.61 Million | -55.33 Million | -69.43 Million |
| Investments in PPE | -489.19 Million | -392.32 Million | -137.62 Million | -59.41 Million | -58.39 Million | -72.81 Million |
| Acquisitions | -35.09 Million | 264.09 Thousand | 110.96 Thousand | 76.85 Thousand | 58.4 Million | 72.61 Thousand |
| Investment purchases | - | -210 Million | -14 Million | -209 Million | -250 Million | -115.14 Million |
| Sales/Maturities of investments | - | 190.45 Million | 14.11 Million | 210.72 Million | 253.05 Million | 117.66 Million |
| Other Investing Activities | 84.73 Thousand | 0.78 | 20.3 Million | -19.99 Million | -58.39 Million | 790.13 Thousand |
| Financing Cash Flow | 553.05 Million | 164.14 Million | 146.31 Million | 261.1 Million | -113.49 Million | 133.44 Million |
| Debt repayment | -594.85 Million | -501.78 Million | -238.57 Million | -98.89 Million | -68.54 Million | -145.03 Million |
| Dividends payments | -31.56 Million | -14.35 Million | -60.01 Million | -7.99 Million | -81 Million | -80.55 Million |
| Common Stock Repurchased | - | - | - | - | 3.98 Million | - |
| Common Stock Issuance | - | - | - | - | -3.98 Million | - |
| Other Financing Activities | -10.23 Million | 680.28 Million | 458.63 Million | 367.99 Million | 40.64 Million | 359.03 Million |
| Accounts receivables | -205.08 Million | -245.05 Million | -34.15 Million | -197.45 Million | -45.72 Million | -112.74 Million |
| Accounts payables | 73.58 Million | 326.9 Million | 20.37 Million | 64.07 Million | -5.17 Million | 56.32 Million |
| Inventory | -59.96 Million | -6.06 Million | -28.79 Million | -35.83 Million | 16.7 Million | -57.84 Million |
| Other working capital | 72.08 Million | 3.02 Million | 6.95 Million | -13.6 Million | -559.75 Thousand | -56.71 Million |
| Cash at beginning of period | 463.84 Million | 472.57 Million | 340.87 Million | 154.08 Million | 178.4 Million | 82.59 Million |
| Cash at end of period | 520.93 Million | 463.84 Million | 472.57 Million | 340.87 Million | 154.08 Million | 178.4 Million |
| Capital Expenditure | -489.19 Million | -392.32 Million | -137.62 Million | -59.41 Million | -58.39 Million | -72.81 Million |
| Effect of forex changes on cash | - | - | 0.44 | 1.33 | - | -0.58 |
| Net cash flow / Change in cash | 57.09 Million | -8.73 Million | 131.7 Million | 186.78 Million | -24.31 Million | 95.8 Million |
| Free Cash Flow | -460.94 Million | -153.61 Million | -35.14 Million | -56.11 Million | 86.11 Million | -41.01 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.13 Million | 49.71 Million | 29.03 Million | 28.99 Million | 112.62 Million | 16.13 Million |
| Depreciation & Amortization | - | 14.2 Million | 14.2 Million | 58.88 Million | 58.88 Million | -26.57 Million |
| Deferred income taxes | - | - | - | - | -1.49 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -111.52 Million | - | -265.04 Million | -192.96 Million | 289.73 Million |
| Other non-cash items | -58.92 Million | 3.8 Million | -219.47 Million | 460.38 Million | 19.07 Million | -373.96 Million |
| Investing Cash Flow | -18.65 Million | -20.47 Million | -91.93 Million | -83.72 Million | -524.21 Million | -102.49 Million |
| Investments in PPE | -18.65 Million | -34.16 Million | -91.93 Million | -83.77 Million | -489.19 Million | -102.49 Million |
| Acquisitions | - | 13.68 Million | 300.00 | 49.84 Thousand | -35.09 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 13.68 Million | 300.00 | 49.84 Thousand | 84.73 Thousand | - |
| Financing Cash Flow | -86.37 Million | 38.92 Million | -1.69 Million | 143.55 Million | 553.05 Million | 157.95 Million |
| Debt repayment | -22.59 Million | -52.87 Million | -8.98 Million | -158.94 Million | -594.85 Million | -287.76 Million |
| Dividends payments | -50.01 Million | -10.75 Million | -9.98 Million | -9.5 Million | -31.56 Million | -8.86 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13.76 Million | -11.47 Million | -688.7 Thousand | -5.89 Million | -10.23 Million | 454.58 Million |
| Accounts receivables | - | -62.93 Million | - | -205.08 Million | -205.08 Million | 194.18 Million |
| Accounts payables | - | - | - | - | 73.58 Million | - |
| Inventory | - | -48.59 Million | - | -59.96 Million | -59.96 Million | 95.55 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 312.91 Million | 251.16 Million | 520.93 Million | 177.89 Million | 463.84 Million | 217.09 Million |
| Cash at end of period | 143.6 Million | 312.91 Million | 236.86 Million | 520.93 Million | 520.93 Million | 177.89 Million |
| Capital Expenditure | -18.65 Million | -34.16 Million | -91.93 Million | -83.77 Million | -489.19 Million | -102.49 Million |
| Effect of forex changes on cash | - | - | - | - | - | 0.14 |
| Net cash flow / Change in cash | -169.3 Million | 61.74 Million | -284.06 Million | 343.03 Million | 57.09 Million | -39.19 Million |
| Free Cash Flow | -72.43 Million | 5.16 Million | -282.37 Million | 199.43 Million | -460.94 Million | -197.15 Million |
141080
HTZWW
034300
DEF
603600
DZRD